| Literature DB >> 31779142 |
Felice Sirico1, Stefano Palermi1, Francesco Gambardella1, Eduardo Capuano1, Umberto Ferrari1, Veronica Baioccato1, Clotilde Castaldo1, Franca Di Meglio1, Daria Nurzynska1.
Abstract
Similar to other peripheral artery diseases, vessel narrowing in popliteal artery entrapment syndrome (PAES) reduces the ankle brachial index (ABI). Since the PAES is related to several anatomical or functional variations, we sought to determine if the ABI was correlated with the type of syndrome. Through a systematic review of literature, we identified case reports and series in which the diagnosis of PAES was accompanied by ABI measurement. Twenty-seven studies included in the qualitative synthesis described 87 limbs. The most common types of the syndrome were those caused by an abnormal medial head of the gastrocnemius (type II, n = 35, 40.23%) and aberrant course of the popliteal artery (type I, n = 20, 22.99%). The variation of plantaris muscle (n = 7, 8.05%) is currently not included in the classification system. The median value of ABI was 0.87 (interquartile range (IQR) = 0.6-1.0). There were no differences among types of syndrome (F = 0.13, p = 0.72). In conclusion, despite clinical recommendations, the ABI remains underused in PAES diagnosis. No correlation was detected between the index score and type of syndrome. The cases of PAES involving structures other than the gastrocnemius or popliteus muscle suggest the need to revisit the current clinical classification system.Entities:
Keywords: ankle brachial index; peripheral artery disease; popliteal artery; skeletal muscle; variation
Year: 2019 PMID: 31779142 PMCID: PMC6947277 DOI: 10.3390/jcm8122071
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Preferred reporting items for systematic reviews and meta-analyses (PRISMA) flowchart of the study selection process.
Summary of the characteristics of the studies included in the analysis.
| Study | Country |
| Sex | Age, Mean (SD) | Side | Classification | ABI, Mean (SD) |
|---|---|---|---|---|---|---|---|
| Ando et al. [ | Japan | 1 | F | 65 | L | N/C | 0.7 |
| Bou and Day [ | The United States | 1 | F | 18 | L | N/C | 1.19 |
| Collins et al. [ | The United States | 11 | 9 M, 2 F | 28.5 (10.2) | 7 R+L, 3 R, 1 L | 1 type I, 6 type II, 5 type III, 6 type IV | 0.92 (0.15) |
| Filis et al. [ | Greece | 1 | M | 27 | R | I | 0.62 |
| Gemayel et al. [ | Switzerland | 1 | M | 27 | R | II | 0.72 |
| Gocen et al. [ | Turkey | 1 | M | 36 | 1 R+L | 2 type I | 0.89 (0.03) |
| Guthrie et al. [ | The United Kingdom | 1 | M | 19 | L | I | 0.3 |
| Imtiaz [ | Pakistan | 1 | M | 32 | R | N/S | 0.5 |
| Iwaki et al. [ | Japan | 1 | M | 59 | 1 R+L | 2 type I | 0.76 (0.21) |
| Iwasaki et al. [ | Japan | 1 | M | 73 | R | III | 0 |
| Jikuya et al. [ | Japan | 1 | M | 22 | 1 R+L | 2 type II | 0.61 (0.23) |
| Jo and Bae [ | South Korea | 1 | M | 30 | R | II | 0.48 |
| Kamphuis et al. [ | Netherlands | 1 | M | 17 | 1 R+L | 2 type I | 0.9 (0.42) |
| Kukreja et al. [ | The United States | 1 | F | 18 | 1 R+L | 2 type VI | 1 (0) |
| Kwon et al. [ | South Korea | 6 | 5 M, 1 F | 32.2 (13.0) | 1 R+L, 3 R, 2 L | N/C | 0.62 (0.26) |
| Lejay et al. [ | France | 18 | 17 M, 1 F | 34.8 (9.72) | 7 R+L, 5 R, 6 L | 4 type I, 17 type II, 2 type III, 2 type VI | 0.83 (0.25) |
| Mailis et al. [ | The United States | 1 | M | 50 | R | N/C | 1 |
| McAree et al. [ | Northern Ireland | 1 | M | 33 | 1 R+L | 2 type II | 0.59 (0.06) |
| McGuinness et al. [ | The United States | 1 | F | 19 | 1 R+L | 2 type II | 0.92 (0.35) |
| Öztoprak et al. [ | Turkey | 1 | F | 22 | R | III | 0.7 |
| Passias et al. [ | The United States | 1 | M | 19 | R | I | 1.02 |
| Politano et al. [ | The United States | 1 | F | 15 | R | I | 0.76 |
| Ring et al. [ | The United States | 2 | N/S | 40 (22.6) | 1 R+L, 1 R | 3 type II | 0.77 (0.13) |
| Sieunarine et al. [ | Australia | 3 | 3 M | 42 (23.3) | 1 L, 2 R | 3 type I | 0.54 (0.07) |
| Sirisena et al. [ | Singapore | 1 | M | 25 | R | II | 0.87 |
| Sugimoto et al. [ | Japan | 1 | M | 73 | 1 R+L | 2 type III | 0.38 (0.01) |
| Symeonidis et al. [ | Australia | 1 | M | 19 | 1 R+L | 2 type I | 1 (0) |
Note: F, female; L, left; M, male; N/C, not included in the current classification system; N/S, not specified; R, right.
Critical evaluation of case reports and case series included in the analysis.
| Study | Demographic Characteristics | Clinical History | Clinical Condition on Presentation | Diagnostic Tests | Treatment | Post Intervention Conditions | Adverse Events | Takeaway Lessons |
|---|---|---|---|---|---|---|---|---|
| Ando et al. [ | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No |
| Bou and Day [ | Yes | No | Yes | Yes | Yes | Yes | Unclear | Yes |
| Collins et al. [ | Yes | Unclear | Yes | Yes | Yes | Unclear | Yes | Yes |
| Filis et al. [ | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes |
| Gemayel et al. [ | Yes | No | Yes | Yes | Yes | Yes | Yes | No |
| Gocen et al. [ | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Guthrie et al. [ | Yes | No | Yes | Yes | Yes | Yes | No | Yes |
| Imitiaz [ | Yes | Yes | Yes | Yes | Yes | Yes | Unclear | No |
| Iwaki et al. [ | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes |
| Iwasaki et al. [ | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes |
| Jikuya et al. [ | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Jo and Bae [ | Yes | Yes | Yes | Yes | Yes | Yes | No | No |
| Kamphuis et al. [ | Yes | No | Yes | Yes | Yes | Yes | Unclear | No |
| Kukreja et al. [ | Yes | Yes | Yes | Yes | Yes | Unclear | No | No |
| Kwon et al. [ | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes |
| Lejay et al. [ | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes |
| Mailis et al. [ | Yes | Yes | Yes | Yes | No | Unclear | No | No |
| McAree et al. [ | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes |
| McGuinness et al. [ | Yes | Unclear | Yes | Yes | Yes | No | Unclear | No |
| Öztoprak et al. [ | Yes | No | Yes | Yes | Yes | Yes | Unclear | No |
| Passias et al. [ | Yes | No | Yes | Yes | Yes | No | Yes | No |
| Politano et al. [ | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No |
| Ring et al. [ | No | No | Yes | Yes | Yes | No | No | No |
| Sieunarine et al. [ | Yes | Unclear | Yes | Yes | Yes | Yes | No | No |
| Sirisena et al. [ | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Sugimoto et al. [ | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No |
| Symeonidis et al. [ | Yes | No | Yes | Yes | Yes | Yes | Yes | No |
Frequencies and median ankle brachial index (ABI) scores in different types of popliteal artery entrapment syndrome (PAES).
| PAES |
| % | Pre-Treatment ABI, Median (Interquartile Range) |
|---|---|---|---|
| Type I | 20 | 22.99 | 0.78 (0.59–0.96) |
| Type II | 35 | 40.23 | 0.90 (0.72–1.00) |
| Type III | 11 | 12.64 | 0.70 (0.39–0.97) |
| Type IV | 6 | 6.90 | 1.00 (1.00–1.00) |
| Type V | 0 | 0 | - |
| Type VI | 4 | 4.60 | 0.95 (0.60–1.00) |
| Unclassified | 11 | 12.64 | 0.63 (0.50–0.95) |